Uptake of metronidazole by human gingival fibroblasts

Journal of Periodontology

Volumn 80, Issue 6, 2009, Pages 993-998

  Yu, Liqiang ^a   Liu, Hongchen ^a   Lingling, E ^a   Wu, Xia ^a   Wang, Dongsheng ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Chemotherapy; Fibroblasts; Gingiva; High performance liquid chromatography; Metronidazole; Uptake

Indexed keywords

ADENINE; AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT; ANTIINFECTIVE AGENT; CATION TRANSPORT PROTEIN; METRONIDAZOLE; PHARMACEUTICAL VEHICLES AND ADDITIVES; PROBENECID;

ADOLESCENT; ARTICLE; BLOOD; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DIFFUSION; DRUG ANTAGONISM; EXTRACELLULAR FLUID; FIBROBLAST; GINGIVA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRACELLULAR FLUID; MALE; METABOLISM; MICROBIOLOGICAL EXAMINATION; PH; TEMPERATURE; TIME;

ADENINE; ADJUVANTS, PHARMACEUTIC; ADOLESCENT; ANTI-INFECTIVE AGENTS; CATION TRANSPORT PROTEINS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIFFUSION; EXTRACELLULAR FLUID; FIBROBLASTS; GINGIVA; HUMANS; HYDROGEN-ION CONCENTRATION; INTRACELLULAR FLUID; MALE; MEMBRANE TRANSPORT MODULATORS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PROBENECID; TEMPERATURE; TIME FACTORS;

EID: 67649980114     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.080617     Document Type: Article

References (38)

1. Liébana J, Castillo AM, Alvarez M. Periodontal diseases: Microbiological considerations. Med Oral Patol Oral Cir Bucal 2004;9(Suppl.):82-91.
2. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144.
3. Beikler T, Prior K, Ehmke B, Flemmig TF. Specific antibiotics in the treatment of periodontitis - A proposed strategy. J Periodontol 2004;75:169-175.
4. Maestre JR. Mixed bacterial infections of the oral cavity (in Spanish). Enferm Infecc Microbiol Clin 2002;20:98-101.
5. Sandor GB, Low DE, Judd PL, Davidson RJ. Antimicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc 1998;64:508-514.
6. Tomás I, Tomás M, Alvarez M, et al. Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials. Oral Microbiol Immunol 2007;22:298-303.
7. Eick S, Pfister W, Straube E. Antimicrobial susceptibility of anaerobic and capnophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis. Int J Antimicrob Agents 1999;12:41-46.
8. Sixou JL, Magaud C, Jolivet-Gougeon A, Cormier M, Bonnaure-Mallet M. Evaluation of the mandibular third molar pericoronitis flora and its susceptibility to different antibiotics prescribed in France. J Clin Microbiol 2003;41:5794-5797.
9. Ready D, Bedi R, Spratt DA, Mullany P, Wilson M. Prevalence, proportions, and identities of antibioticresistant bacteria in the oral microflora of healthy children. Microb Drug Resist 2003;9:367-372.
10. Yang Q, Nakkula RJ, Walters JD. Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts. J Dent Res 2002;81:836-840.
11. Zavarella MM, Gbemi O, Walters JD. Accumulation of non-steroidal anti-inflammatory drugs by gingival fibroblasts. J Dent Res 2006;85:452-456.
12. Ciancio SG, Mather ML, McMullen JA. An evaluation of minocycline in patients with periodontal disease. J Periodontol 1980;51:530-534.
13. Conway TB, Beck FM, Walters JD. Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites. J Periodontol 2000;71:1448-1452.
14. Rotzetter PA, Le Liboux A, Pichard E, Cimasoni G. Kinetics of spiramycin/metronidazole (Rodogyl) in human gingival crevicular fluid, saliva and blood. J Clin Periodontol 1994;21:595-600.
15. Pähkla ER, Koppel T, Saag M, Pähkla R. Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitis. J Clin Periodontol 2005;32:163-166.
16. Britt MR, Pohlod DJ. Serum and crevicular fluid concentrations after a single oral dose of metronidazole. J Periodontol 1986;57:104-107.
17. Lee W, Kim RB. Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol 2004;44:137-166.
18. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007; 24:1227-1251.
19. Griffith DA, Jarvis SM. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1996;1286:153-181.
20. Mariotti A, Cochran DL. Characterization of fibroblasts derived from human periodontal ligament and gingiva. J Periodontol 1990;61:103-111.
21. Wu X, Liu H, Liu Y, E L, Wang D, Lv Y. The transmembrane transport of metronidazole and tinidazole by osteoblast from rat's mandible (in Chinese). Chin J Prosthodont 2007;8:59-62.
22. The Chinese Pharmacopoeia. Pharmacopoeia Commission, Ministry of Health of PRC, 2005 ed. Beijing: PRC Chemical Industry Press; 2005:123.
23. Gao N, Li L, Shi Z, Zhang X, Jin W. High-throughput determination of glutathione and reactive oxygen species in single cells based on fluorescence images in a microchannel. Electrophoresis 2007;28:3966-3975.
24. Hand WL, King-Thompson N, Holman JW. Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1987;31:1553-1557.
25. Hand WL, King-Thompson NL. Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts. Antimicrob Agents Chemother 1990;34:1189-1193.
26. Xiuwen Q, Gang Wu, Rongchang Li, Jingfen L, Kui W. Studies on the structures of Pt(IV) anticancer complexes and kinetics and mechanism of their cellular uptake (in Chinese). Chin Pharm J 2004;39:292-295.
27. Zhang TL, Gao YX, Lu JF, Wang K. Arsenite, arsenate and vanadate affect human erythrocyte membrane. J Inorg Biochem 2000;79:195-203.
28. Jensen JC, Gugler R. Single and multiple-dose metronidazole kinetics. Clin Pharmacol Ther 1983;34: 481-487.
29. Loft S, Døssing M, Poulsen HE, et al. Influence of dose and route of administration on disposition of metronidazole and its major metabolites. Eur J Clin Pharmacol 1986;30:467-473.
30. Schwartz DE, Jeunet F. Comparative pharmacokinetic studies of ornidazole and metronidazole in man. Chemotherapy 1976;22:19-29.
31. Carcas AJ, Guerra P, Frias J, et al. Gender differences in the disposition of metronidazole. Int J Clin Pharmacol Ther 2001;39:213-218.
32. Elder MG, Kane JL. The pelvic tissue levels achieved by metronidazole after single or multiple dosing: Oral and rectal. In: Phillips R, Collier J, eds. Metronidazole: Proceedings of the Second International Symposium on Anaerobic Infections. New York: Academic Press; 1979:55-58.
33. Bassi C, Pederzoli P, Vesentini S, et al. Behavior of antibiotics during human necrotizing pancreatitis. Antimicrob Agents Chemother 1994;38:830-836.
34. Nagar H, Berger SA, Hammar B, Gorea A. Penetration of clindamycin and metronidazole into the appendix and peritoneal fluid in children. Eur J Clin Pharmacol 1989;37:209-210.
35. Amon I, Amon K, Scharp H, Franke G, Nagel F. Disposition kinetics of metronidazole in children. Eur J Clin Pharmacol 1983;24:113-119.
36. Passmore CM, McElnay JC, Rainey EA, D'Arcy PF. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988; 26:45-51.
37. Warner JF, Perkins RL, Cordero L. Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess. Arch Intern Med 1979;139:167-169.
38. Martinez V, Caumes E. Metronidazole (in French). Ann Dermatol Venereol 2001;128:903-909.